Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey.

ABSTRACT:

Background

Neuromuscular blocking agents (NMBAs) and neuromuscular monitoring in anesthetic management are integral for endotracheal intubation, better visualization of the surgical field, and prevention of residual neuromuscular blockade and pulmonary complications. Sugammadex is a drug that reduces risk of residual neuromuscular blockade, with more rapid recovery compared to anticholinesterase. The purpose of this study was to investigate current usage status of NMBAs and antagonist with neuromuscular monitoring, among anesthesiologists in Korea.

Methods

Anesthesiologists working in Korea were invited to participate in an online survey via email January 2-February 28, 2018. The questionnaire consisted of 45 items, including preferred NMBAs, antagonists, neuromuscular monit

SUBMITTER: Kim JS 

PROVIDER: S-EPMC7713803 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature